Firefly Neuroscience (NASDAQ:AIFF) Shares Down 3% – Here’s What Happened

Firefly Neuroscience, Inc. (NASDAQ:AIFF) shares were down 3% on Friday . The stock traded as low as $2.49 and last traded at $2.62. Approximately 21,768 shares traded hands during trading, a decline of 73% from the average daily volume of 82,088 shares. The stock had previously closed at $2.70.

Firefly Neuroscience Trading Down 3.0 %

The business’s 50 day moving average is $3.08.

Hedge Funds Weigh In On Firefly Neuroscience

An institutional investor recently bought a new position in Firefly Neuroscience stock. Waldron Private Wealth LLC purchased a new stake in shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,000 shares of the company’s stock, valued at approximately $36,000. Waldron Private Wealth LLC owned 1.79% of Firefly Neuroscience at the end of the most recent reporting period. Hedge funds and other institutional investors own 4.96% of the company’s stock.

About Firefly Neuroscience

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.